Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

MREOMREO
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in MEREO BIOPHARMA GROUP PLC

GOLDMAN SACHS GROUP INC holds 85,180 shares of MREO (MEREO BIOPHARMA GROUP PLC), worth $27,062 as of 2026-Q2. This is a new position.

Current Value

$27,062

Current Shares

85,180

Total Value Change

-$7.4M

Total Shares Change

-2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
85,180
-
$27,0620.0%$0.32
30
2026-Q1
Exited
0
-100.0%
$00.0%$0.41
0
2025-Q4
Decreased
28,026
-98.8%
$11,6780.0%$0.37
0
2025-Q3
Decreased
2.4M
-23.5%
$4.9M0.0%$1.96
0
2025-Q2
Increased
3.1M
+45.4%
$8.4M0.0%$2.66
37
2025-Q1
Increased
2.1M
+0.3%
$4.8M0.0%$2.30
27
2024-Q4
New
2.1M
-
$7.4M0.0%$3.52
38

Other major holders of MREO: Janus Henderson Group Ltd., ADAGE CAPITAL PARTNERS GP, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used